retatrutide 4mg Retatrutide Results: 28.3% Weight Loss
Description
For patients with well-controlled Graves disease who are euthyroid on antithyroid medications or following definitive treatment (radioactive iodine or thyroidectomy), tirzepatide may be considered if there are appropriate indications such as type 2 diabetes or obesity (BMI 30 kg/m or 27 kg/m with weight-related comorbidities)
If all criteria are met, the system can auto-generate an approval
A.KoehlerJ
This approach ensures adequate nutrition despite eating less overall
